首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1490035

全球抗病毒藥物市場：按藥物類別、類型、應用、分銷管道、地區

Antiviral Drugs Market, By Drug Class, By Type, By Application, By Distribution Channel, By Geography

出版日期: 2024年05月16日 | 出版商:

Coherent Market Insights | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年全球抗病毒藥物市場規模估計達636.6億美元，2024年至2031年年複合成長率為5.10%，2031年將達899.5億美元。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	636.6億美元
實際資料	2019-2023	預測期	2024-2031
預測2024-2031年年複合成長率：	5.10%	2031年金額預測	899.5億美元

圖：2024年依地區分類的抗病毒藥物市場佔有率（%）

過去幾年，全球抗病毒藥物市場穩定成長。抗病毒藥，也稱為抗感染疾病藥物，是一類專門用於治療病毒引起的感染疾病的藥物。抗病毒藥物透過抑制病毒的產生並防止病毒在體內傳播來發揮作用。愛滋病毒/愛滋病、肝炎和流感等病毒性疾病的日益普及推動全球對抗病毒藥物的需求。根據世界衛生組織（WHO）統計，2020年全球約有 3,670 萬人感染愛滋病毒。

市場動態：

全球抗病毒藥物市場的成長是由病毒感染疾病和流行病發生率上升所推動的。 COVID-19大流行的出現進一步增加了對治療抗病毒藥物的需求。政府的有利支持和醫療保健設施支出的增加也推動了市場的成長。然而，與藥物發現和開發相關的高成本以及嚴格的監管核准限制市場擴張。從積極的一面來看，增加新型抗病毒治療的研發預計將在未來幾年為參與者創造有利的機會。

本研究的主要特點

本報告對全球抗病毒藥物市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球抗病毒藥物市場的主要企業。
主要企業包括 AbbVie Inc.、GSK plc、Dr. Reddy's Laboratories Ltd.、F. Hoffmann-La Roche Ltd.、Bristol-Myers Squibb Company、Cipla、Aurobindo Pharma、Gilead Sciences, Inc.、Merck & Co., Inc.、Zydus Group、Atea Pharmaceuticals、Johnson & Johnson Services, Inc.、Sun Pharmaceutical Industries Ltd.、Pfizer Inc.、Torrent Pharmaceuticals Ltd.、Arbutus Biopharma、Divi's Laboratories Limited、RedHill Biopharma Ltd.、ViiV Healthcare Pty Ltd. 等。
本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球抗病毒藥物市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球抗病毒藥物市場的各種策略矩陣來促進決策。

公司簡介
- AbbVie Inc.
- GSK plc
- Dr. Reddy's Laboratories Ltd.
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Cipla
- Aurobindo Pharma
- Gilead Sciences, Inc.
- Merck &Co., Inc.
- Zydus Group
- Atea Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Torrent Pharmaceuticals Ltd.
- Arbutus Biopharma
- Divi's Laboratories Limited
- RedHill Biopharma Ltd.
- ViiV Healthcare Pty Ltd.

第11章分析師建議

第12章參考文獻與調查方法

簡介目錄

Product Code: CMI4912

Global antiviral drugs market is estimated to be valued at USD 63.66 Bn in 2024 and is expected to reach USD 89.95 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 63.66 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	5.10%	2031 Value Projection:	US$ 89.95 Bn

Figure. Antiviral Drugs Market Share (%), By Region, 2024

The global antiviral drugs market has been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agents or anti-infective medications, are a class of medication used specifically for treating infections caused by viruses. They work by inhibiting the production of viruses or preventing their spread in the body. Rising prevalence of viral diseases such as HIV/AIDS, hepatitis, influenza and others have been fueling demand for antiviral medications globally. According to the World Health Organization (WHO), around 36.7 million people were living with HIV worldwide in 2020.

Market Dynamics:

The global antiviral drugs market growth is driven by the growing incidence of viral infections and pandemics. The emergence of COVID-19 pandemic has further augmented the demand for antiviral drugs for treatment. Favorable government support and rising expenditure on healthcare facilities are also propelling the market growth. However, high costs associated with drug discovery and development as well as stringent regulatory approvals are restraining the market expansion. On the positive side, increasing R&D for developing novel antiviral therapeutics is expected to create lucrative opportunities for players in the coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global antiviral drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global antiviral drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes AbbVie Inc., GSK plc, Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Cipla, Aurobindo Pharma, Gilead Sciences, Inc., Merck & Co., Inc., Zydus Group, Atea Pharmaceuticals, Johnson & Johnson Services, Inc., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Torrent Pharmaceuticals Ltd., Arbutus Biopharma, Divi's Laboratories Limited, RedHill Biopharma Ltd., ViiV Healthcare Pty Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global antiviral drugs market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antiviral drugs market.

Detailed Segmentation-

By Drug Class:
- DNA Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Neuraminidase Inhibitors
- Others
By Type:
- Branded
- Generics
By Application:
- HIV
- Hepatitis
- Herpes
- Influenza
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AbbVie Inc.
- GSK plc
- Reddy's Laboratories Ltd.
- Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Cipla
- Aurobindo Pharma
- Gilead Sciences, Inc.
- Merck & Co., Inc.
- Zydus Group
- Atea Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Torrent Pharmaceuticals Ltd.
- Arbutus Biopharma
- Divi's Laboratories Limited
- RedHill Biopharma Ltd.
- ViiV Healthcare Pty Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Antiviral Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Antiviral Drugs Market, By Drug Class, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
DNA Polymerase Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Reverse Transcriptase Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Protease Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neuraminidase Inhibitors
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Antiviral Drugs Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Antiviral Drugs Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
HIV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Herpes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Antiviral Drugs Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Antiviral Drugs Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dr. Reddy's Laboratories Ltd.
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Cipla
- Aurobindo Pharma
- Gilead Sciences, Inc.
- Merck & Co., Inc.
- Zydus Group
- Atea Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Torrent Pharmaceuticals Ltd.
- Arbutus Biopharma
- Divi's Laboratories Limited
- RedHill Biopharma Ltd.
- ViiV Healthcare Pty Ltd.